bioRxivMicrobiologyPreprint
An epitope-resurfaced virus-like particle can induce broad neutralizing antibody against four serotypes of dengue virus
Wen-Fan Shen, Jedhan Ucat Galula, Jyung-Hurng Liu, Mei-Ying Liao, Chang-Hao Huang, Yu-Chun Wang, Han-Chung WuiD, Jian-Jong Liang, Yi-Ling Lin, Matthew T. Whitney, Gwong-Jen J. ChangiD, Sheng-Ren Chen, Shang-Rung Wu, Day-Yu ChaoiD
Abstract
Dengue fever is caused by four different serotypes of dengue virus (DENV) which is the leading cause of worldwide arboviral diseases in humans. Virus-like particles (VLPs) containing flavivirus prM/E proteins have been demonstrated to be a potential vaccine candidate; however, the structure of dengue VLP is poorly understood. Herein we show for the first time that mD2VLP particles possess a T=1 icosahedral symmetry with a groove located within the E-protein dimers near the 2-fold vertices that exposed highly overlapping, cryptic neutralizing epitopes through cryo-electron microscopy reconstruction. Mice vaccinated with highly matured virus-like particles derived from DENV serotype 2 (mD2VLP) can generate higher cross reactive (CR) neutralization antibodies (NtAbs) and were protected against all 4 serotypes of DENV through clonal expansion supported by hybridoma and B-cell repertoire analysis. Our results revealed that a \"epitope-resurfaced\" mature-form dengue VLP has the potential to induce quaternary structure-recognizing broad CR NtAbs.
- organism: human
- assay: cryo-EM
- research focus: host-pathogen & immune response
- approach: experimental assay
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- A dengue monovalent vaccine with novel structure provides cross-protection against four serotypes of dengue virus
Day-Yu Chao, Wen-Fan Shen, … Shang-Rung Wu·bioRxiv·Mar 5, 2018
- A Tetravalent Dengue Virus-like Particle Vaccine Induces High levels of Neutralizing Antibodies and Inhibits Dengue Replication in Non-Human Primates
D. Thoresen, K. Matsuda, … W. akahata·bioRxiv·Oct 16, 2023
- Cross-reactivity reduced dengue virus serotype 2 vaccine does not confer cross-protection against other serotypes of dengue viruses
J. U. Galula, C.-Y. Yang, … D.-Y. Chao·Future VirologyPeer-reviewed·Mar 23, 2020
- Multivalent administration of dengue E dimers on liposomes elicits type-specific neutralizing responses without immune interference
Thanh T.N. Phan, Devina Thiono, … Brian A. Kuhlman·npj VaccinesPeer-reviewed·Jun 9, 2025
- Structural basis of broadly neutralizing human antibodies targeting diverse dengue virus forms.
Ananya Chatterjee, Ankush Roy, … Vidya Mangala Prasad·bioRxiv·Apr 27, 2026
- A mRNA-LNP vaccine against Dengue Virus elicits robust, serotype-specific immunity
C. J. Wollner, M. C. Richner, … J. M. Richner·bioRxiv·Jan 5, 2021